Sponsor content
3 result(s) found, displaying 1 to 3
-
Prescription medicine decision summaryEkterly (sebetralstat) has been approved for hereditary angioedema (HAE) attacks caused by C1 inhibitor deficiency or dysfunction, in patients aged 12 years and older.
-
-